Kepos Capital’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Kepos Capital’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-250,000	Closed	-$19K	–	291
2023 Q2	$19K	Buy	+250,000	New	+$29.8K	﹤0.01%	288
2022 Q4	$25K	Hold	250,000	–	–	﹤0.01%	305
2022 Q3	$8K	Hold	250,000	–	–	﹤0.01%	433
2022 Q2	$12K	Hold	250,000	–	–	﹤0.01%	471
2022 Q1	$20K	Hold	250,000	–	–	﹤0.01%	598
2021 Q4	$81K	Hold	250,000	–	–	0.01%	554
2021 Q3	$65K	Hold	250,000	–	–	﹤0.01%	547
2021 Q2	$135K	Buy	+250,000	New	+$127K	0.01%	429

Other funds holding COEPW

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Kepos Capital's COEPW Position: Q3 2023 in Review

Kepos Capital sold out of Coeptis Therapeutics Warrants (COEPW) in Q3 2023, closing a stake of 250,000 shares — an estimated $19K sold.

Kepos Capital first reported a position in COEPW in Q2 2021 and held it in 8 quarters. The position peaked at $135K in Q2 2021. 19 funds tracked by Wall St. Rank hold COEPW as of Q3 2023.

Kepos Capital reported no remaining Coeptis Therapeutics Warrants position as of Q3 2023 after selling out during the quarter.
Kepos Capital sold 250,000 Coeptis Therapeutics Warrants shares in Q3 2023, an estimated $19K.
Kepos Capital first reported a position in Coeptis Therapeutics Warrants in Q2 2021 and held it in 8 quarters.
Kepos Capital's Coeptis Therapeutics Warrants position peaked at $135K in Q2 2021.
19 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q3 2023.

Based on Kepos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.